Most skincare stimulates the skin. The CEL™ helps it regulate itself, then regenerate.
Less than 3% of ageing is genetic. The rest is shaped by epigenetic factors - stress, environment, lifestyle, nutrition. CEL™ was created to address these epigenetic shifts, supporting the skin’s ability to function, regenerate, and endure.
What happened when we tested it on real human skin.
Ex vivo. Independent anatomical pathology laboratory. Healthy, undamaged tissue. No UV stress. No induced damage of any kind.
Most skincare efficacy testing stops at the petri dish - isolated cells, treated with a single ingredient, measured in a culture medium. We commissioned an independent anatomical pathology laboratory to test the CEL™ complex on intact human skin tissue, epidermis and dermis together, under a microscope. The skin was healthy throughout. Its response was spontaneous.
Procollagen I level consistent with skin of a 25-yr old or below
Peer-reviewed research shows that elderly skin expresses approximately half the procollagen I of young adult skin - a decline of roughly 50% over a lifetime. In 56-year-old skin tissue, a single application of the CEL™ complex was associated with 34.76% more cells in the dermis actively producing procollagen I versus baseline. The measurement was the same method as the peer reviewed study: immunofluorescence counting of procollagen I positive cells in intact human skin tissue.
The magnitude of that single-application response is comparable to reversing the full extent of age-related procollagen I decline documented in the peer-reviewed literature - bringing the production level to one consistent with skin aged 25 or below.
The skin's own maintenance system, activating. Documented for the first time after a topical application.
Healthy young skin has an internal management system. It continuously evaluates which cells are working well, repairs what it can, and removes what it cannot. In aging skin, this system slows down. Cells that should be cleared accumulate. The tissue gradually loses its ability to manage itself.
After a single application on healthy, undamaged skin tissue, two markers of that maintenance system rose significantly over 4.5 hours. The first coordinates the evaluation and repair process. The second carries out the selective renewal. Both rose together, in tissue that was never injured or stressed before the test. No other topical skincare product has produced this specific pattern in published science.
The independent pathologist's conclusion: a coordinated cellular renewal response. Not a reaction to damage. An activation of the skin's own intelligence.
Tested on healthy skin. Not damaged skin. That distinction is huge.
There is something the skincare industry almost never tells you about how it tests products.
The standard approach in cosmetic efficacy testing is to damage skin cells or tissue first - usually with UV radiation - before applying the product. The reasons the numbers look good are built into the method itself. UV radiation first suppresses procollagen production, creating an artificially low baseline. Then the skin triggers its own repair response, independently driving procollagen back up - with or without the product. The product gets credit for both.
This study chose the harder test. The tissue was never damaged. No artificially low baseline. No repair response riding underneath the result. And in that healthy, undamaged tissue, +34.76% more cells in the dermis were actively producing procollagen I versus baseline. Not recovering. Not rebounding. Producing - because the CEL™ complex restored the conditions for cells that were always capable of it.
The skin was not harmed. It produced.
The study was conducted on CEL™ Reset Serum, a professional treatment available through medical dispensing. CEL™ Reset Serum is the finished product of CEL™ Complex.
FAQ
What exactly is in the CEL™ complex and what makes it different?
CEL stands for Cellular Epigenetic Longevity. A patent-pending bioactive blend of plant-derived exosomes, peptides, and botanical extracts, developed in our French epigenetic research laboratory. Formulated to work in calibrated cycles, supporting the skin's natural renewal processes through intermittent, dose-dependent action.
What does longevity skincare actually mean - and how is it different from anti-aging?
Longevity skincare focuses on supporting the skin's own biological maintenance over time - not correcting surface signs after they appear, but creating the conditions for skin to stay healthier for longer. At Skin Diligent, this means working at the level of how skin cells read and act on their own instructions, rather than simply stimulating the surface.
How do I know the science is real and not just marketing?
The CEL™ complex has been evaluated in independent ex vivo anatomical pathology testing on real human skin tissue - measuring procollagen I synthesis, p53 activation, and caspase-3 modulation in healthy, undamaged skin. No UV stress or induced damage was applied. The skin's response was spontaneous.
What happened to the skin in the study?
Within 30 minutes of a single application, the CEL™ complex was associated with a +93.75% increase in procollagen I in the outer skin layer, sustained at +131.25% at 4.5 hours and measurable in the dermis at +34.76%. p53 - the cell's principal quality-control protein - rose to +520.25% above baseline. Caspase-3 rose to +151.56% at 4.5 hours - consistent with the skin's own coordinated maintenance process becoming active. Tissue architecture remained intact throughout. The skin was healthy at every timepoint. No damage was induced before the test.
Why does it matter that you tested the finished product and not just an ingredient?
Skin Diligent is the only skincare brand to test the finished formula for estrogenic and androgenic endocrine disruption across the complete formula. The CEL™ complex has been evaluated in independent ex vivo anatomical pathology on real human skin tissue, producing results consistent with the skin's own cellular quality-control mechanism activating.
Sources
Varani J, June 2006, American Journal Of Pathology 168(6):1861-8. Fisher GJ, Datta SC, Talwar HS, et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature. 1996;379(6563):335-339. Quan T, Qin Z, Xia W, Shao Y, Voorhees JJ, Fisher GJ. Matrix-degrading metalloproteinases in photoaging. Journal of Investigative Dermatology Symposium Proceedings. 2009;14(1):20-24. Varani J, Dame MK, Rittie L, et al. Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitro. American Journal of Pathology. 2006;168(6):1861-1868. Lichtman MK, Otero-Vinas M, Falanga V. Transforming growth factor beta (TGF-beta) isoforms in wound healing and fibrosis. Wound Repair and Regeneration. 2016;24(2):215-222. Finnson KW, McLean S, Di Guglielmo GM, Philip A. Dynamics of transforming growth factor beta signaling in wound healing and scarring. Advances in Wound Care. 2013;2(5):195-214.